Irindalone structure
|
Common Name | Irindalone | ||
---|---|---|---|---|
CAS Number | 96478-43-2 | Molecular Weight | 408.51200 | |
Density | 1.219g/cm3 | Boiling Point | 605.7ºC at 760mmHg | |
Molecular Formula | C24H29FN4O | Melting Point | N/A | |
MSDS | N/A | Flash Point | 320.1ºC |
Use of IrindaloneIrindalone is a novel serotonin 5-HT2 antagonist. |
Name | 1-[2-[4-[(1R,3S)-3-(4-fluorophenyl)-2,3-dihydro-1H-inden-1-yl]piperazin-1-yl]ethyl]imidazolidin-2-one |
---|---|
Synonym | More Synonyms |
Description | Irindalone is a novel serotonin 5-HT2 antagonist. |
---|---|
Related Catalog | |
Target |
5-HT2[1] |
In Vitro | Irindalone causes a concentration-related inhibition of serotonin-induced contractions and shifts the serotonin curve to the right. Irindalone is more potent in inhibiting the serotonin-induced contractions. Irindalone has a similar profile in vitro, with a high affinity for serotonin 5-HT2 receptors and about a 10 times lower affinity for α1-adrenoceptors[1]. |
In Vivo | Irindalone dose dependently lowers the blood pressure in spontaneously hypertensive rats (SHR) and renal hypertensive dogs[1]. |
References |
Density | 1.219g/cm3 |
---|---|
Boiling Point | 605.7ºC at 760mmHg |
Molecular Formula | C24H29FN4O |
Molecular Weight | 408.51200 |
Flash Point | 320.1ºC |
Exact Mass | 408.23300 |
PSA | 38.82000 |
LogP | 3.18770 |
Index of Refraction | 1.6 |
Storage condition | 2-8℃ |
Precursor 3 | |
---|---|
DownStream 0 |
Irindalona |
Irindalone |
Irindalonum |
UNII-4F39T8N10K |